Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,632 | -28,634 | -16,158 | -16,829 | -17,855 |
| Depreciation Amortization | 3,224 | 1,693 | 915 | 995 | 1,310 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 7 |
| Accounts receivable | 201 | -1,643 | -978 | 4,286 | 655 |
| Other Working Capital | 1,025 | -5,070 | 5 | 1,754 | -1,123 |
| Other Operating Activity | 2,091 | 6,893 | -494 | -3,001 | 4,260 |
| Operating Cash Flow | $-14,091 | $-26,761 | $-16,710 | $-12,795 | $-12,746 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,129 | -3,727 | -707 | -96 | -207 |
| Investing Cash Flow | $-1,129 | $-3,727 | $-707 | $-96 | $-207 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 6,140 | 2,500 |
| Debt Repayment | -165 | -1,000 | N/A | -3,700 | 0 |
| Common Stock Issued | 11,410 | 5,603 | 31,114 | 22,258 | 9,175 |
| Common Stock Repurchased | N/A | N/A | -1,135 | -1,281 | -821 |
| Other Financing Activity | 6,189 | 0 | -25 | 932 | -133 |
| Financing Cash Flow | $17,434 | $4,603 | $29,954 | $24,349 | $10,721 |
| Exchange Rate Effect | 171 | -109 | -238 | 317 | -23 |
| Beginning Cash Position | 4,181 | 30,175 | 17,876 | 6,101 | 8,356 |
| End Cash Position | 6,566 | 4,181 | 30,175 | 17,876 | 6,101 |
| Net Cash Flow | $2,385 | $-25,994 | $12,299 | $11,775 | $-2,255 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,091 | -26,761 | -16,710 | -12,795 | -12,746 |
| Capital Expenditure | -1,311 | -3,727 | -707 | -96 | -207 |
| Free Cash Flow | -15,402 | -30,488 | -17,417 | -12,891 | -12,953 |